Advances in breast imaging: Magnetic resonance imaging

被引：17
作者：
Bartella L. [1 ]
Morris E.A. [1 ]
机构：
[1] Department of Radiology, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10021
来源：
Current Oncology Reports | 2006年 / 8卷 / 1期
关键词：
Breast Cancer; Magnetic Resonance Imaging; Magn Reson Image; Breast Magnetic Resonance Imaging; Breast Conservation Therapy;
D O I：
10.1007/s11912-006-0003-y
中图分类号：
学科分类号：
摘要：
Magnetic resonance imaging (MRI) of the breast is rapidly becoming incorporated into clinical practice. Indications for breast MRI include staging of known breast cancer, monitoring response to chemotherapy, assessing recurrence, problem solving, and high-risk screening. Magnetic resonance spectroscopy is a promising technique that may decrease the number of benign biopsies generated by breast MRI in the clinical setting. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：7 / 13
页数：6
相关论文
共 61 条
[51]  
Cecil K.M., Schnall M.D., Siegelman E.S., Lenkinski R.E., The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy, Breast Cancer Res Treat, 68, pp. 45-54, (2001)
[52]  
Roebuck J.R., Cecil K.M., Schnall M.D., Lenkinski R.E., Human breast lesions: Characterization with proton MR spectroscopy, Radiology, 209, pp. 269-275, (1998)
[53]  
Gribbestad I.S., Singstad T.E., Nilsen G., Et al., In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil, J Magn Reson Imaging, 8, pp. 1191-1197, (1998)
[54]  
Tse G.M., Cheung H.S., Pang L.M., Et al., Characterization of lesions of the breast with proton MR spectroscopy: Comparison of carcinomas, benign lesions, and phyllodes tumors, AJR Am J Roentgenol, 181, pp. 1267-1272, (2003)
[55]  
Bolan P.J., Meisamy S., Baker E.H., Et al., In vivo quantification of choline compounds in the breast with 1H MR spectroscopy, Magn Reson Med, 50, pp. 1134-1143, (2003)
[56]  
Huang W., Fisher P.R., Dulaimy K., Et al., Detection of breast malignancy: Diagnostic MR protocol for improved specificity, Radiology, 232, pp. 585-591, (2004)
[57]  
Jacobs M.A., Barker P.B., Bottomley P.A., Et al., Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study, J Magn Reson Imaging, 19, pp. 68-75, (2004)
[58]  
Jagannathan N.R., Kumar M., Seenu V., Et al., Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer, Br J Cancer, 84, pp. 1016-1022, (2001)
[59]  
Meisamy S., Bolan P.J., Baker E.H., Et al., Neoadjuvant chemotherapy of locally advanced breast cancer: Predicting response with in vivo (1)H MR spectroscopy - A pilot study at 4 T, Radiology, 233, pp. 424-431, (2004)
[60]  
Bartella L., Proton MR spectroscopy (MRS) using choline signal as malignancy marker improves specificity compared to conventional MRI in diagnosis of breast cancer: A preliminary study, Radiology, 233, (2004)
1234567